NO20032482L - Forbindelser som er spesifikke overfor adenosin-A1, A2A og A< N>3-reseptor samt anvendelse derav - Google Patents

Forbindelser som er spesifikke overfor adenosin-A1, A2A og A< N>3-reseptor samt anvendelse derav

Info

Publication number: NO20032482L
Authority: NO; Norway
Prior art keywords: adenosine; receptor; compounds specific; compounds; specific
Prior art date: 2000-12-01

Application number

NO20032482A

Other languages

English (en)

Other versions

NO20032482D0 (no

NO327207B1 (no

Inventor

Arlindo Lucas Castelhano

Bryan Mckibben

David J Witter

Original Assignee

Osi Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-01

Filing date

2003-06-02

Publication date

2003-07-28

2000-12-01 Priority claimed from US09/728,607 external-priority patent/US6664252B2/en

2000-12-01 Priority claimed from US09/728,616 external-priority patent/US7160890B2/en

2000-12-01 Priority claimed from US09/728,316 external-priority patent/US6680322B2/en

2003-06-02 Application filed by Osi Pharm Inc filed Critical Osi Pharm Inc

2003-06-02 Publication of NO20032482D0 publication Critical patent/NO20032482D0/no

2003-07-28 Publication of NO20032482L publication Critical patent/NO20032482L/no

2009-05-11 Publication of NO327207B1 publication Critical patent/NO327207B1/no

Links

OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title 2
239000002126 C01EB10 - Adenosine Substances 0.000 title 1
229960005305 adenosine Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20032482A 2000-12-01 2003-06-02 Forbindelser som er spesifikke overfor adenosin-A1, A2A og A3-reseptor samt anvendelse derav for fremstilling av medikamenter og fremgangsmate for fremstilling av forbindelsene NO327207B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US09/728,607 US6664252B2 (en)	1999-12-02	2000-12-01	4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US09/728,616 US7160890B2 (en)	1999-12-02	2000-12-01	Compounds specific to adenosine A3 receptor and uses thereof
US09/728,316 US6680322B2 (en)	1999-12-02	2000-12-01	Compounds specific to adenosine A1 receptors and uses thereof
PCT/US2001/045280 WO2002057267A1 (en)	2000-12-01	2001-11-30	Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof

Publications (3)

Publication Number	Publication Date
NO20032482D0 NO20032482D0 (no)	2003-06-02
NO20032482L true NO20032482L (no)	2003-07-28
NO327207B1 NO327207B1 (no)	2009-05-11

Family

ID=27419112

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032482A NO327207B1 (no)	2000-12-01	2003-06-02	Forbindelser som er spesifikke overfor adenosin-A1, A2A og A3-reseptor samt anvendelse derav for fremstilling av medikamenter og fremgangsmate for fremstilling av forbindelsene

Country Status (20)

Country	Link
EP (1)	EP1347980A4 (no)
JP (1)	JP4579497B2 (no)
CN (1)	CN1263757C (no)
AP (1)	AP1893A (no)
AU (1)	AU2002248151B2 (no)
BR (1)	BR0115847A (no)
CA (1)	CA2430577A1 (no)
CZ (1)	CZ20031831A3 (no)
EA (1)	EA007254B1 (no)
HU (1)	HUP0400692A3 (no)
IL (1)	IL155962A0 (no)
ME (1)	MEP35308A (no)
MX (1)	MXPA03004717A (no)
NO (1)	NO327207B1 (no)
NZ (1)	NZ525885A (no)
OA (1)	OA13295A (no)
PL (1)	PL363245A1 (no)
WO (1)	WO2002057267A1 (no)
YU (1)	YU42703A (no)
ZA (1)	ZA200303729B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5090531A (en) *	1990-01-10	1992-02-25	Lord Corporation	Electrophoretic fluid differential
IL139787A0 (en)	1998-06-02	2002-02-10	Osi Pharm Inc	PYRROLO [2, 3d] PYRIMIDINE COMPOSITIONS AND THEIR USE
US6680324B2 (en)	2000-12-01	2004-01-20	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A1 receptors and uses thereof
DE10148883A1 (de) *	2001-10-04	2003-04-10	Merck Patent Gmbh	Pyrimidinderivate
DE60234118D1 (de) *	2001-11-30	2009-12-03	Osi Pharm Inc	Verbindungen, die für Adenosin A1 und A3 Rezeptoren spezifisch sind, und deren Anwendungen
CA2469316A1 (en) *	2001-12-07	2003-06-19	Vertex Pharmaceuticals, Inc.	Pyrimidine-based compounds useful as gsk-3 inhibitors
US20030229067A1 (en)	2001-12-20	2003-12-11	Arlindo Castelhano	Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
BR0215202A (pt)	2001-12-20	2004-10-13	Osi Pharm Inc	Compostos antagonistas seletivos a2b de pirimidina, sua sìntese e uso
AU2003270701B2 (en) *	2002-10-31	2009-11-12	Amgen Inc.	Antiinflammation agents
HUP0203976A3 (en) *	2002-11-15	2004-08-30	Sanofi Aventis	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
UY29177A1 (es)	2004-10-25	2006-05-31	Astex Therapeutics Ltd	Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
MY179032A (en)	2004-10-25	2020-10-26	Cancer Research Tech Ltd	Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
ATE464904T1 (de) *	2005-02-18	2010-05-15	Solvay Pharm Gmbh	Pharmazeutische zusammensetzungen mit nep- inhibitoren, inhibitoren des endogenes endothelin produzierenden systems und diuretika
JP5606734B2 (ja)	2006-04-25	2014-10-15	アステックス、セラピューティックス、リミテッド	医薬化合物
US20070260203A1 (en) *	2006-05-04	2007-11-08	Allergan, Inc.	Vasoactive agent intraocular implant
TW200808819A (en) *	2006-06-19	2008-02-16	Solvay Pharm Gmbh	Use of adenosine A1 antagonists in radiocontrast media induced nephrophaty
BRPI0818533B8 (pt)	2007-10-11	2021-05-25	Astrazeneca Ab	composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
WO2009098715A2 (en)	2008-01-11	2009-08-13	Natco Pharma Limited	Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
AR070127A1 (es)	2008-01-11	2010-03-17	Novartis Ag	Pirrolo - pirimidinas y pirrolo -piridinas
WO2012131399A1 (en)	2011-04-01	2012-10-04	Astrazeneca Ab	Therapeutic treatment
PT2785349T (pt)	2011-11-30	2019-12-11	Astrazeneca Ab	Tratamento combinado de cancro
AU2013204533B2 (en)	2012-04-17	2017-02-02	Astrazeneca Ab	Crystalline forms
HK1202112A1 (en) *	2012-06-07	2015-09-18	霍夫曼-拉罗奇有限公司	Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
WO2015004533A2 (en)	2013-06-21	2015-01-15	Zenith Epigenetics Corp.	Novel substituted bicyclic compounds as bromodomain inhibitors
SG11201510409QA (en)	2013-06-21	2016-01-28	Zenith Epigenetics Corp	Novel bicyclic bromodomain inhibitors
AU2014298051B2 (en)	2013-07-31	2018-11-15	Zenith Epigenetics Ltd.	Novel quinazolinones as bromodomain inhibitors
WO2016087942A1 (en)	2014-12-01	2016-06-09	Zenith Epigenetics Corp.	Substituted pyridines as bromodomain inhibitors
WO2016087936A1 (en)	2014-12-01	2016-06-09	Zenith Epigenetics Corp.	Substituted pyridinones as bromodomain inhibitors
CN107207474B (zh)	2014-12-11	2021-05-07	恒翼生物医药科技(上海)有限公司	被取代的杂环作为溴结构域抑制剂
CA2966450A1 (en)	2014-12-17	2016-06-23	Olesya KHARENKO	Inhibitors of bromodomains
AU2016208906B2 (en) *	2015-01-20	2018-07-12	Wuxi Fortune Pharmaceutical Co., Ltd	JAK inhibitor
UA119701C2 (uk)	2015-04-29	2019-07-25	Вуксі Фортуне Фармасьютікал Ко., Лтд	Піримідинові сполуки як jak-інгібітори
DK3305788T3 (da)	2015-05-29	2020-09-28	Wuxi Fortune Pharmaceutical Co Ltd	Janus-kinase-hæmmer
CN105771672B (zh) *	2016-04-18	2018-03-02	天津工业大学	一种抗污染抗菌芳香聚酰胺反渗透复合膜及制备方法
US11066413B2 (en) *	2017-03-07	2021-07-20	Guangzhou Maxinovel Pharmaceuticals Co., Ltd.	Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereof
CN108017584B (zh) *	2017-06-20	2021-03-23	南开大学	A3腺苷受体的小分子拮抗剂
WO2019233994A1 (en) *	2018-06-04	2019-12-12	Exscientia Ltd	Pyrazolopyrimidine compounds as adenosine receptor antagonists
CN110128316B (zh) *	2019-05-22	2021-08-31	北京大学深圳研究生院	5位取代的β-脯氨酸及其衍生物的制备方法
CN110272373B (zh) *	2019-07-02	2022-07-29	天津国际生物医药联合研究院	一种具有选择性的腺苷a1受体拮抗剂及其应用
CN114085178A (zh) *	2021-12-29	2022-02-25	苏州楚凯药业有限公司	一种4-甲基-1-丙基-2-氨基-1h-吡咯-3-腈的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2128544T3 (es) *	1992-12-17	1999-05-16	Pfizer	Pirrolopirimidinas como antagonistas del crf.
US5780450A (en) *	1995-11-21	1998-07-14	Alcon Laboratories, Inc.	Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
IL139787A0 (en) *	1998-06-02	2002-02-10	Osi Pharm Inc	PYRROLO [2, 3d] PYRIMIDINE COMPOSITIONS AND THEIR USE
WO2001039777A1 (en) *	1999-12-02	2001-06-07	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof
DE60234118D1 (de) *	2001-11-30	2009-12-03	Osi Pharm Inc	Verbindungen, die für Adenosin A1 und A3 Rezeptoren spezifisch sind, und deren Anwendungen

2001
- 2001-11-30 IL IL15596201A patent/IL155962A0/xx unknown
- 2001-11-30 OA OA1200300148A patent/OA13295A/en unknown
- 2001-11-30 AP APAP/P/2003/002807A patent/AP1893A/en active
- 2001-11-30 PL PL01363245A patent/PL363245A1/xx not_active Application Discontinuation
- 2001-11-30 HU HU0400692A patent/HUP0400692A3/hu unknown
- 2001-11-30 WO PCT/US2001/045280 patent/WO2002057267A1/en not_active Ceased
- 2001-11-30 ME MEP-353/08A patent/MEP35308A/xx unknown
- 2001-11-30 AU AU2002248151A patent/AU2002248151B2/en not_active Ceased
- 2001-11-30 MX MXPA03004717A patent/MXPA03004717A/es active IP Right Grant
- 2001-11-30 NZ NZ525885A patent/NZ525885A/en active IP Right Revival
- 2001-11-30 YU YU42703A patent/YU42703A/sh unknown
- 2001-11-30 CA CA002430577A patent/CA2430577A1/en not_active Abandoned
- 2001-11-30 CN CNB018224601A patent/CN1263757C/zh not_active Expired - Fee Related
- 2001-11-30 BR BR0115847-3A patent/BR0115847A/pt not_active Application Discontinuation
- 2001-11-30 CZ CZ20031831A patent/CZ20031831A3/cs unknown
- 2001-11-30 JP JP2002557944A patent/JP4579497B2/ja not_active Expired - Fee Related
- 2001-11-30 EA EA200300628A patent/EA007254B1/ru not_active IP Right Cessation
- 2001-11-30 EP EP01997029A patent/EP1347980A4/en not_active Ceased
2003
- 2003-05-14 ZA ZA200303729A patent/ZA200303729B/en unknown
- 2003-06-02 NO NO20032482A patent/NO327207B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2430577A1 (en)	2002-07-25
JP2004517896A (ja)	2004-06-17
EP1347980A4 (en)	2005-02-09
CN1263757C (zh)	2006-07-12
IL155962A0 (en)	2003-12-23
OA13295A (en)	2007-04-13
WO2002057267A1 (en)	2002-07-25
BR0115847A (pt)	2004-02-25
AP2003002807A0 (en)	2003-06-30
AU2002248151B2 (en)	2008-02-21
MXPA03004717A (es)	2004-06-30
AP1893A (en)	2008-09-23
CZ20031831A3 (cs)	2004-05-12
ZA200303729B (en)	2004-05-14
NZ525885A (en)	2005-01-28
YU42703A (sh)	2006-03-03
NO20032482D0 (no)	2003-06-02
MEP35308A (en)	2011-02-10
EA200300628A1 (ru)	2003-12-25
EP1347980A1 (en)	2003-10-01
HUP0400692A2 (hu)	2004-07-28
EA007254B1 (ru)	2006-08-25
CN1489590A (zh)	2004-04-14
JP4579497B2 (ja)	2010-11-10
HUP0400692A3 (en)	2007-09-28
NO327207B1 (no)	2009-05-11
PL363245A1 (en)	2004-11-15

Legal Events

Date	Code	Title	Description
2011-06-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20032482D0 (no)	2003-06-02	Forbindelser som er spesifikke overfor adenosin-A1, A2A og A< N>3-reseptor samt anvendelse derav
PT1056759E (pt)	2003-01-31	Derivados do 2-(purin-9-il)-tetrahidrofurano-3,4-diolc
ATE256141T1 (de)	2003-12-15	N-pyrazol a2a rezeptor agonisten
ATE240341T1 (de)	2003-05-15	C-pyrazol a2a rezeptor agonisten
MA26878A1 (fr)	2004-12-20	Regulateurs de recepteurs d'adenosine
NO20032735L (no)	2003-08-06	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
MXPA03001775A (es)	2003-06-04	Derivados de nucleosidos.
DE60110219D1 (de)	2005-05-25	Adenosin a2a rezeptor antagonisten
NO20022573D0 (no)	2002-05-30	N6-heterosykliske, 8-modifiserte adenosinderivater
DE60209251D1 (de)	2006-04-20	Adenosine a2a receptor antagonisten
PT1192170E (pt)	2003-09-30	Agonistas de receptor a2a de propargilfenileter
DE69934814D1 (de)	2007-02-22	Nichtzirkuläre mikro-bohrung
NO20032483L (no)	2003-07-30	Kondenserte purinderivater som A<N>1<N/>-adenosinreseptor-antagonister
ATE257484T1 (de)	2004-01-15	6,9-verbrückte erythromycin-derivate
ATE239750T1 (de)	2003-05-15	6,11-verbrückte erythromycinderivate
ID28539A (id)	2001-05-31	Imidazo (1,2a) azina bersubstitusi sebagai penghambat selektif cox-2
AU2001247227A1 (en)	2001-09-03	2-thioether a2a receptor agonists
NO975344D0 (no)	1997-11-21	Anordning ved brönn, spesielt ved tilhörende rigg
DE69928065D1 (de)	2005-12-08	Transfermechanismus
IT247521Y1 (it)	2002-08-22	Maniglione antipanico .
IT247441Y1 (it)	2002-08-22	Maniglione antipanico .
GB0010292D0 (en)	2000-06-14	A adenosine receptor agonists
IT1308149B1 (it)	2001-11-29	Pinza portautensile modificata.
ZA200204153B (en)	2004-11-24	Compounds specific to adenosine A3, A2A, and A3 receptor and uses thereof.
HK1058933A (en)	2004-06-11	Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof